About Accutar Biotechnology
Accutar Biotechnology is a company based in Brooklyn (United States) founded in 2015 by Jie Fan. Accutar Biotechnology has raised $91.45 million across 5 funding rounds from investors including Primavera Capital Group, YITU and Yunfeng Capital. Accutar Biotechnology offers products and services including ChemiRise, Orbital, Virtual Screen, Intelligent-SAR, and Chemi-Net. Accutar Biotechnology operates in a competitive market with competitors including Formation Bio, Owkin, BigHat, Benchsci and Predictive Oncology, among others.
- Headquarter Brooklyn, United States
- Founders Jie Fan
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Accutar Biotechnology Inc.
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$91.45 M (USD)
in 5 rounds
-
Latest Funding Round
Not available
-
Investors
Primavera Capital Group
& 7 more
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Accutar Biotechnology
Accutar Biotechnology offers a comprehensive portfolio of products and services, including ChemiRise, Orbital, Virtual Screen, Intelligent-SAR, and Chemi-Net.
AI tool for accelerating chemical compound discovery.
Virtual screening platform for drug candidate identification.
System for intelligent drug design and analysis.
Tool for structure-activity relationship predictions.
Network for chemical data modeling and predictions.
People of Accutar Biotechnology
Unlock access to complete
Unlock access to complete
Funding Insights of Accutar Biotechnology
Accutar Biotechnology has successfully raised a total of $91.45M across 5 strategic funding rounds. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Accutar Biotechnology
Accutar Biotechnology has secured backing from 8 investors, including venture fund and institutional investors. Prominent investors backing the company include Primavera Capital Group, YITU and Yunfeng Capital.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Private equity investments are managed by Yunfeng Capital in China.
|
Locked | Locked | Locked | |
|
Provider of an investment platform for various stages
|
Locked | Locked | Locked | |
|
-
|
Locked | Locked | Locked |
Investor details for Accutar Biotechnology
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Accutar Biotechnology
Investment portfolio details for Accutar Biotechnology
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Accutar Biotechnology
Detailed financials for Accutar Biotechnology
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Accutar Biotechnology Comparisons
Peer comparison for Accutar Biotechnology
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Accutar Biotechnology
Accutar Biotechnology operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Formation Bio, Owkin, BigHat, Benchsci and Predictive Oncology, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
AI-powered drug discovery platform for various diseases
|
|
| Locked | Locked | Locked |
An agentic AI platform is developed for biomedical research insights.
|
|
| Locked | Locked | Locked |
Antibody therapies are developed through machine learning and synthetic biology.
|
|
| Locked | Locked | Locked |
AI platform used for extracting antibody data from scientific papers.
|
|
| Locked | Locked | Locked |
AI-based platform for cancer diagnostics and precision medicine is utilized.
|
|
| Locked | Locked | Locked |
AI-driven drug discovery platform for the treatment of cancer
|
Detailed competitors of Accutar Biotechnology
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Accutar Biotechnology
Complete news archive for Accutar Biotechnology
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Accutar Biotechnology
Accutar Biotechnology was founded in 2015 and raised its 1st funding round 2 years after it was founded.
Accutar Biotechnology is headquartered in Brooklyn, United States. It is registered at Brooklyn, New York, United States.
Jie Fan is the current CEO of Accutar Biotechnology. They have also founded this company.
Accutar Biotechnology is a funded company, having raised a total of $91.45M across 5 funding rounds to date.
Accutar Biotechnology was founded in 2015 and is based in Brooklyn, United States. Operations focus on computation-aided drug discovery within the biotechnology sector. An AI-assisted tool has been developed for predicting drug pocket side-chain conformations and performing drug docking, with accuracy exceeding standard methods. Chemical compound properties, such as solubility and binding affinity, are also predicted. Platforms include Orbital Docking and One-click Docking for these functions.
Accutar Biotechnology's top competitors include Owkin, Formation Bio and XtalPi.
Accutar Biotechnology offers ChemiRise, Orbital, Virtual Screen, Intelligent-SAR, and Chemi-Net.
Accutar Biotechnology has 8 investors. Key investors include Primavera Capital Group, YITU, Yunfeng Capital, Coatue, and 3W Partners.